Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist
Yan Zhou, Kevin B. Freeman, Vincent Setola, Danni Cao, Shane W Kaski, Mary Jeanne Kreek, Lee‐Yuan Liu‐Chen
Topics & Concepts
Trk receptorAnhedoniaPharmacologyAgonistMedicineNociceptionReceptorInternal medicineNerve growth factorDopaminePharmacological Effects of Natural CompoundsPain Mechanisms and TreatmentsDermatology and Skin Diseases